"Medical Crossfire®: Translating Recent Data into Informed Sequencing Decisions in Advanced Non-Small-Cell Lung Cancer" is an ancillary symposium to the 17th Annual International Lung Cancer Congress®.
This interactive and dynamic session will aid physicians in assessing the wealth of new data, choosing treatment based upon patient and tumor characteristics, and applying those findings to their practices. This case-based activity will serve to update practitioners on advances in the field, with a particular focus on optimized advanced strategies for patients with non-small-cell lung cancer, practical information concerning how to assess response and when to switch therapies, and multidisciplinary methods to facilitate proactive management of treatment-related adverse effects. The activity will utilize a variety of formats, including presentation of new data, clinical scenarios exploring the evidence behind treatment decisions and adverse event management, and faculty Q&A to encourage peer-to-peer and peer-to-expert interactions, as well as, the sharing of best practices.
Upon completion of this activity, participants will be able to:
This educational activity is directed toward oncologists, nurse practitioners (NPs), nurses, and physician assistants (PAs) involved in the treatment and management of patients with lung cancers. Pharmacists, researchers, fellows, and other healthcare professionals interested in the treatment of lung cancers may also participate.
|Thursday, August 4, 2016|
|7:15 PM||Welcome and Presession Survey||David R. Gandara, MD|
|7:20 PM||State of Advanced NSCLC Management in 2016: First-line Therapy||Giorgio Scagliotti, MD, PhD|
|7:25 PM||Advanced Squamous NSCLC in the Front-line Setting: Critical Decision Points||David R. Gandara, MD; Edward B. Garon, MD, MS; Suresh Ramalingam, MD; Giorgio Scagliotti, MD, PhD|
|7:40 PM||State of Advanced NSCLC Management in 2016: Second-line and Beyond||David R. Gandara, MD|
|7:45 PM||Advanced NSCLC Beyond Disease Progression: Critical Decision Points||David R. Gandara, MD; Edward B. Garon, MD, MS; Suresh Ramalingam, MD; Giorgio Scagliotti, MD, PhD|
|8:10 PM||Postsession Survey and Concluding Remarks||David R. Gandara, MD|
|8:15 PM||Adjourn||David R. Gandara, MD|
Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 1.0 Contact Hours.
Jan 30, 2018
Community Practice Connections™: 1st Annual European Congress on Hematology™: Focus on Lymphoid Malignancies
Jan 30, 2018
Cancer Summaries and Commentaries™: Update from San Diego - Advances in the Treatment of Multiple Myeloma
Jan 31, 2018
Jan 31, 2018